J&J Unit Challenges $12M Verdict as Rival Seeks Increased Damages
By Editorial Team
A recent legal battle has unfolded in a Delaware federal court as Johnson & Johnson subsidiary DePuy Synthes contests a $12 million verdict imposed by a jury for allegedly infringing on spinal fusion patents owned by RSB Spine. The dispute centers around the doctrine of equivalents, with DePuy Synthes arguing that the jury’s decision was erroneous.
DePuy Synthes, a prominent player in the medical device industry, is determined to challenge the verdict, claiming that the amount awarded to RSB Spine is unjustified. On the other side, RSB Spine is pushing for an increase in damages, intensifying the legal showdown between the two companies.
The legal proceedings have attracted significant attention, with law firm Ashby & Geddes, Cooley LLP, Jones Day, and Phillips McLaughlin representing the parties involved. The case is being overseen by Judge Richard G. Andrews at the U.S. District Court for the District of Delaware.
The patents at the center of the dispute are 7,846,207 for an intervertebral implant and 9,713,537 for a bone plate stabilization system and its method of use. The outcome of this legal battle could have far-reaching implications for both companies and the broader medical device industry.
As the legal saga continues to unfold, stakeholders eagerly await further developments in this high-stakes intellectual property dispute. The case underscores the importance of protecting intellectual property rights and the complex legal battles that can arise in the competitive landscape of the medical device sector.
